MedTrace Logo

Post Operative Sensitivity of MTA Obturation

NCT06795282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2026-01-02

No results posted yet for this study

Summary

The aim of this study was to investigate the difference in postoperative pain caused by different root canal sealers in patients with irreversible pulpitis symptoms and no apical lesions.

Conditions

  • Dental Pulp Disease
  • Endodontically Treated Teeth
  • Endodontic Disease

Interventions

DRUG

MTA

MTA is primarily composed of tricalcium silicate, dicalcium silicate, bismuth oxide (for radiopacity), and small amounts of calcium sulfate. MTA is highly biocompatible, making it suitable for use in the root canal system and areas in close contact with tissues.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-30
Primary Completion
2025-12-01
Completion
2025-12-15
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06795282 on ClinicalTrials.gov